RNS Number : 0256Z
Coventry Building Society
07 January 2020
 

RNS Announcement

 

Publication of SUPPLEMENTAL pROSPECTUS

 

The following Supplemental Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

Supplemental Prospectus dated 7 January 2020 (the Supplemental Prospectus) relating to €7 billion Global Covered Bond Programme of Coventry Building Society, unconditionally and irrevocably guaranteed as to payments by Coventry Building Society Covered Bonds LLP.

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/0256Z_1-2020-1-7.pdf

 

The Supplemental Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

 

For further information, please contact

 

Thomas Crane

General Counsel and Secretary

Coventry Building Society

Telephone: 02476 435506

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplemental Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the relevant Supplemental Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Supplemental Prospectus is not addressed. Prior to relying on the information contained in the relevant Supplemental Prospectus you must ascertain from the relevant Supplemental Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement. 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPEAAFXELFEEFA